Advent Technologies Holdings, Inc. (NASDAQ: ADN) (“Advent” or the
“Company”), an innovation-driven leader in the fuel cell and
hydrogen technology space, today announced consolidated financial
results for the three months ended June 30, 2024. All amounts are
in U.S. dollars unless otherwise noted and have been prepared in
accordance with U.S. generally accepted accounting principles
(“GAAP”).
Q2 2024
Financial Highlights
(All comparisons are to Q2 2023, unless otherwise stated)
- Revenue of $0.8 million and income from grants of $0.7 million,
for a total of $1.5 million.
- Operating expenses of $10.0 million, a year-over-year decrease
of $1.2 million, primarily related to the streamlining of
operations.
- Net loss in Q2 of $(11.3) million or $(4.28) per share.
- Unrestricted cash reserves were $0.7 million as of June 30,
2024, a decrease of $0.1 million from March 31, 2024.
“We are on the road to becoming a much leaner and focused
company with the goal to substantially reduce our cash burn. We aim
to soon rely mostly on customer revenue and R&D grants for our
operations rather than on fundraising. Towards that goal, we are
focusing our activities on our Livermore and Patras offices that
are leading the US Army, Airbus, and R&D product development
efforts. Technology-wise, we have made great progress with the
Advent MEA and expect to announce strong performance improvements
to the market by year-end. I am thankful to our employees in the
USA and Greece for performing excellent work during these hard
financial times and meeting all customer milestones and
requirements,” said Dr. Vasilis Gregoriou, Chairman and CEO of
Advent Technologies.
Business Updates
Airbus: The second quarter milestones were completed
successfully, and the cooperation between the two companies
continues to be strong. Aviation has by far the most challenging
requirements compared to any other market. Advent believes that the
benchmark performance achieved through this project will also be
instrumental in achieving the performance requirements of other
markets, especially stationary power, marine, and automotive.
The project aims to accelerate the development of Advent’s MEA
and benchmark the Ion Pair MEA against aviation requirements and
current/expected technological limits. HT-PEM MEAs operating at
temperatures higher than 180°C (360°F) aim to solve one of the
largest challenges in aviation fuel cell use: thermal management.
High-temperature fuel cells allow increased performance, increased
passenger carrying capability, and increased range compared to
low-temperature fuel cell stack technology.
US Army: Work continued at a good pace in the two new contracts
with the U.S. Department of Defense (“DoD”) ($2.2m and $2.8m
awarded in 2023). Advent has successfully met all program
milestones so far (on time or with minor delays) and the demanding
mission requirements of the U.S. Army. These contracts are the
continuation of a series of past contracts with the U.S. DoD, and
their primary objective is to further optimize Advent’s proprietary
Honey Badger 50™ (“HB50”) portable fuel cell system by integrating
the Company’s innovative Ion Pair MEA technology. Upon the
completion of these contracts, Advent and the U.S. DoD aim to
reinforce their long-term collaboration by focusing on the further
optimization of the HB50 and also on low-volume production
manufacturing capacity.
Advent continued work for the ten EU-received R&D grants
that are already ongoing and met milestones in multi-partner
projects focused on further developing its technology and
accelerating its product development roadmap.
Advent continued work on developing the Advent MEA with the goal
to eventually achieve three times (3x) the power density
performance and the 3x the lifetime performance of the legacy MEA
that has been used for the last years across the line of Serene
products. Advent believes that the development of the MEA is
essential to continue and precede mass market efforts. The
experience with the Serene systems is that despite their design and
system maturity they remain too expensive for the markets intended
(especially telecom power backup in Asia and Africa). The expected
introduction of the Advent MEA into new fuel cell systems
codeveloped with OEMs can bring the cost three times down
effectively creating an inflection point for mass adoption.
Other Updates
Reverse Stock Split: On May 1, 2024, Advent announced that it
would move forward with a 1-for-30 reverse stock split of its
issued and outstanding common stock. The reverse stock split was
approved on April 30, 2024 by Advent’s Board of Directors,
following approval by the Company's stockholders at a special
meeting held on April 29, 2024. The reverse stock split brought
Advent back into compliance with Nasdaq's $1.00 per share minimum
bid price requirement for continued listing and to make the
Company's stock more attractive to a broader range of institutional
and other investors. On May 9, 2024 Advent announced that it would
file a Certificate of Amendment to its Second Amended and Restated
Certificate of Incorporation with the Secretary of State of
Delaware after the close of business on Monday, May 13, 2024 to
effectuate its previously announced 1-for-30 reverse stock split of
its issued and outstanding common stock (the “Reverse Split”).
Dr. Gregoriou concluded, “We have continued our work on
important projects with Airbus, US Army, Hyundai, and other
automotive manufacturers. We are happy to report that despite
financial difficulties, we have put our full focus and effort into
these projects, and we have done our best work to date, meeting all
the milestones. On the contrary, the Advent Denmark subsidiary has
had poor financial and technology delivery performance, leading us
to implement more cuts there. We intend to continue to reduce costs
and focus our operations and people on what is truly world-changing
and a competitive advantage for the company, and that is our Advent
MEA technology. Furthermore, we are currently in talks with OEMs
with the intention to enter into technology transfer
agreements.”
About Advent
Technologies Holdings,
Inc.
Advent Technologies Holdings, Inc. (a U.S. corporation) is an
advanced materials and technology development company operating in
the fuel cell, methanol, and hydrogen technology space. Advent is a
world-leading company in the development of the HT-PEM technology
(with more than 100 patents issued, pending, or licensed
worldwide). The HT-PEM fuel cell technology developed by Advent
enables off-grid power systems to produce clean power from various
green fuels (hydrogen, methanol, bio and eMethanol, and renewable
natural gas) and to function with higher efficiency at extreme
ambient temperatures and in general extreme environmental
conditions (humidity, air pollution). Advent’s main operations
focus on developing and manufacturing the Membrane Electrode
Assembly (MEA), which is the core electrochemical element and the
most critical component of the fuel cell. The MEA largely
determines lifetime, power density, efficiency, and overall cost of
installation and operation for all applications. Advent is working
with world-leading market-leading OEMs with the goal of bringing to
the market complete fuel cell systems for a range of applications
in the stationary power markets (backup, off-grid, and portable
power) and the heavy-duty mobility markets (automotive, aviation,
marine).For more information, please visit www.advent.energy.
Cautionary Note
Regarding Forward-Looking
Statements
This press release includes forward-looking statements. These
forward-looking statements generally can be identified by the use
of words such as “anticipate,” “expect,” “plan,” “could,” “may,”
“will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and
other words of similar meaning. Each forward-looking statement
contained in this press release is subject to risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied by such statement. Applicable risks
and uncertainties include, among others, the Company’s ability to
maintain the listing of the Company’s common stock on Nasdaq;
future financial performance; public securities’ potential
liquidity and trading; impact from the outcome of any known and
unknown litigation; ability to forecast and maintain an adequate
rate of revenue growth and appropriately plan its expenses;
expectations regarding future expenditures; future mix of revenue
and effect on gross margins; attraction and retention of qualified
directors, officers, employees, and key personnel; ability to
compete effectively in a competitive industry; ability to protect
and enhance our corporate reputation and brand; expectations
concerning our relationships and actions with our technology
partners and other third parties; impact from future regulatory,
judicial and legislative changes to the industry; ability to locate
and acquire complementary technologies or services and integrate
those into the Company’s business; future arrangements with, or
investments in, other entities or associations; and intense
competition and competitive pressure from other companies worldwide
in the industries in which the Company will operate; and the risks
identified under the heading “Risk Factors” in our Annual Report on
Form 10-K filed with the Securities and Exchange Commission on
August 13, 2024, as well as the other information we file with the
SEC. We caution investors not to place considerable reliance on the
forward-looking statements contained in this press release. You are
encouraged to read our filings with the SEC, available at
www.sec.gov, for a discussion of these and other risks and
uncertainties. The forward-looking statements in this press release
speak only as of the date of this document, and we undertake no
obligation to update or revise any of these statements. Our
business is subject to substantial risks and uncertainties,
including those referenced above. Investors, potential investors,
and others should give careful consideration to these risks and
uncertainties.
Presentation of
Non-GAAP Financial
Measures
In addition to the results provided in accordance with U.S. GAAP
throughout this press release, the Company has provided non-GAAP
financial measures - Adjusted Net Income / (Loss) and Adjusted
EBITDA - which present results on a basis adjusted for certain
items. The Company uses these non-GAAP financial measures for
business planning purposes and in measuring its performance
relative to that of its competitors. The Company believes that
these non-GAAP financial measures are useful financial metrics to
assess its operating performance from period-to- period by
excluding certain items that the Company believes are not
representative of its core business. These non- GAAP financial
measures are not intended to replace, and should not be considered
superior to, the presentation of the Company’s financial results in
accordance with GAAP. The use of the terms Adjusted Net Income /
(Loss) and Adjusted EBITDA may differ from similar measures
reported by other companies and may not be comparable to other
similarly titled measures. These measures are reconciled from the
respective measures under GAAP in the appendix below.
ADVENT TECHNOLOGIES HOLDINGS,
INC.CONDENSED CONSOLIDATED BALANCE
SHEETS(Amounts in USD thousands, except share and
per share amounts) |
|
|
|
As of |
|
|
|
June 30,2024 |
|
|
December 31,2023 |
|
|
|
(Unaudited) |
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
682 |
|
|
$ |
3,562 |
|
Restricted cash, current |
|
|
- |
|
|
|
100 |
|
Accounts receivable, net |
|
|
922 |
|
|
|
191 |
|
Contract assets |
|
|
11 |
|
|
|
21 |
|
Inventories |
|
|
1,986 |
|
|
|
2,707 |
|
Prepaid expenses and Other current assets |
|
|
3,314 |
|
|
|
2,254 |
|
Total current assets |
|
|
6,915 |
|
|
|
8,835 |
|
Non-current assets: |
|
|
|
|
|
|
|
|
Intangibles, net |
|
|
76 |
|
|
|
79 |
|
Property and equipment, net |
|
|
6,734 |
|
|
|
21,549 |
|
Right-of-use assets |
|
|
341 |
|
|
|
3,216 |
|
Restricted cash, non-current |
|
|
- |
|
|
|
750 |
|
Other non-current assets |
|
|
303 |
|
|
|
308 |
|
Available for sale financial asset |
|
|
- |
|
|
|
- |
|
Total non-current assets |
|
|
7,454 |
|
|
|
25,902 |
|
Total assets |
|
$ |
14,369 |
|
|
$ |
34,737 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Trade and other payables |
|
$ |
6,283 |
|
|
$ |
5,087 |
|
Deferred income from grants, current |
|
|
7 |
|
|
|
530 |
|
Contract liabilities |
|
|
2,221 |
|
|
|
2,015 |
|
Loss contingency liabilities |
|
|
5,162 |
|
|
|
- |
|
Other current liabilities |
|
|
1,768 |
|
|
|
1,916 |
|
Operating lease liabilities |
|
|
162 |
|
|
|
2,186 |
|
Income tax payable |
|
|
176 |
|
|
|
179 |
|
Total current liabilities |
|
|
15,779 |
|
|
|
11,913 |
|
Non-current liabilities: |
|
|
|
|
|
|
|
|
Bonds and other long-term debt, net |
|
|
537 |
|
|
|
- |
|
Warrant liability |
|
|
- |
|
|
|
59 |
|
Long-term operating lease liabilities |
|
|
170 |
|
|
|
8,230 |
|
Defined benefit obligation |
|
|
91 |
|
|
|
83 |
|
Deferred income from grants, non-current |
|
|
- |
|
|
|
320 |
|
Other long-term liabilities |
|
|
671 |
|
|
|
684 |
|
Total non-current liabilities |
|
|
1,469 |
|
|
|
9,376 |
|
Total liabilities |
|
|
17,248 |
|
|
|
21,289 |
|
|
|
|
|
|
|
|
|
|
Commitments and contingent liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders’ equity |
|
|
|
|
|
|
|
|
Common stock ($0.0001 par value per share; Shares authorized:
500,000,000 at June 30, 2024 and December 31, 2023;
Issued and outstanding: 2,636,508 and 2,580,159 at June 30,
2024 and December 31, 2023, respectively) |
|
|
- |
|
|
|
- |
|
Preferred stock ($0.0001 par value per share; Shares authorized:
1,000,000 at June 30, 2024 and December 31, 2023; nil
issued and outstanding at June 30, 2024 and December 31,
2023) |
|
|
- |
|
|
|
- |
|
Additional paid-in capital |
|
|
199,265 |
|
|
|
194,941 |
|
Accumulated other comprehensive loss |
|
|
(2,356 |
) |
|
|
(2,334 |
) |
Accumulated deficit |
|
|
(199,788 |
) |
|
|
(179,159 |
) |
Total stockholders’ equity / (deficit) |
|
|
(2,879 |
) |
|
|
13,448 |
|
Total liabilities and stockholders’ equity |
|
$ |
14,369 |
|
|
$ |
34,737 |
|
ADVENT TECHNOLOGIES HOLDINGS,
INC.CONDENSED CONSOLIDATED STATEMENTS OF
OPERATIONS(Amounts in USD thousands, except share
and per share amounts) |
|
|
|
Three months
endedJune 30,(Unaudited) |
|
|
Six months
endedJune 30,(Unaudited) |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Revenue, net |
|
$ |
805 |
|
|
$ |
1,112 |
|
|
$ |
4,256 |
|
|
$ |
2,089 |
|
Cost of revenues |
|
|
(155 |
) |
|
|
(1,905 |
) |
|
|
(1,174 |
) |
|
|
(3,389 |
) |
Gross loss |
|
|
650 |
|
|
|
(793 |
) |
|
|
3,082 |
|
|
|
(1,300 |
) |
Income from grants |
|
|
677 |
|
|
|
660 |
|
|
|
2,114 |
|
|
|
1,194 |
|
Research and development expenses |
|
|
(3,587 |
) |
|
|
(2,883 |
) |
|
|
(5,002 |
) |
|
|
(6,024 |
) |
Administrative and selling expenses |
|
|
(6,372 |
) |
|
|
(8,331 |
) |
|
|
(13,275 |
) |
|
|
(16,820 |
) |
Sublease income |
|
|
- |
|
|
|
138 |
|
|
|
145 |
|
|
|
265 |
|
Amortization of intangibles |
|
|
(1 |
) |
|
|
(188 |
) |
|
|
(2 |
) |
|
|
(409 |
) |
Credit loss – customer contracts |
|
|
- |
|
|
|
(127 |
) |
|
|
- |
|
|
|
(127 |
) |
Impairment losses |
|
|
- |
|
|
|
(9,763 |
) |
|
|
- |
|
|
|
(9,763 |
) |
Operating loss |
|
|
(8,633 |
) |
|
|
(21,287 |
) |
|
|
(12,938 |
) |
|
|
(32,984 |
) |
Fair value change of warrant liability |
|
|
- |
|
|
|
99 |
|
|
|
59 |
|
|
|
489 |
|
Finance income / (expenses), net |
|
|
(54 |
) |
|
|
8 |
|
|
|
(286 |
) |
|
|
118 |
|
Foreign exchange gains / (losses), net |
|
|
(156 |
) |
|
|
159 |
|
|
|
(165 |
) |
|
|
118 |
|
Loss contingency |
|
|
36 |
|
|
|
|
|
|
|
(4,871 |
) |
|
|
|
|
Other income / (expenses), net |
|
|
(2,466 |
) |
|
|
(806 |
) |
|
|
(2,483 |
) |
|
|
(760 |
) |
Loss before income tax |
|
|
(11,273 |
) |
|
|
(21,827 |
) |
|
|
(20,684 |
) |
|
|
(33,019 |
) |
Income taxes |
|
|
- |
|
|
|
(4 |
) |
|
|
55 |
|
|
|
(800 |
) |
Net loss |
|
$ |
(11,273 |
) |
|
$ |
(21,831 |
) |
|
$ |
(20,629 |
) |
|
$ |
(33,819 |
) |
Net loss per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per share |
|
|
(4.28 |
) |
|
|
(12.26 |
) |
|
|
(7.91 |
) |
|
|
(19.25 |
) |
Basic weighted average number of shares |
|
|
2,634,179 |
|
|
|
1,780,574 |
|
|
|
2,609,549 |
|
|
|
1,757,137 |
|
Diluted loss per share |
|
|
(4.28 |
) |
|
|
(12.26 |
) |
|
|
(7.91 |
) |
|
|
(19.25 |
) |
Diluted weighted average number of shares |
|
|
2,634,179 |
|
|
|
1,780,574 |
|
|
|
2,609,549 |
|
|
|
1,757,137 |
|
ADVENT TECHNOLOGIES HOLDINGS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH
FLOWS(Amounts in USD thousands, except share and
per share amounts) |
|
|
|
Six Months
EndedJune 30,(unaudited) |
|
|
(Amounts in thousands) |
|
2024 |
|
|
2023 |
|
|
$ change |
|
|
% change |
|
Net Cash used in Operating Activities |
|
$ |
(4,810 |
) |
|
$ |
(18,899 |
) |
|
$ |
14,089 |
|
|
|
(74.5 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from sale of property and equipment |
|
|
300 |
|
|
|
- |
|
|
|
300 |
|
|
|
N/A |
|
Purchases of property and equipment |
|
|
(28 |
) |
|
|
(2,348 |
) |
|
|
2,320 |
|
|
|
(98.8 |
)% |
Advances for the acquisition of property and equipment |
|
|
- |
|
|
|
(1,214 |
) |
|
|
1,214 |
|
|
|
N/A |
|
Acquisition of subsidiaries |
|
|
- |
|
|
|
(1,864 |
) |
|
|
1,864 |
|
|
|
N/A |
|
Net Cash provided by / (used in) Investing
Activities |
|
$ |
272 |
|
|
$ |
(5,426 |
) |
|
$ |
5,698 |
|
|
|
(105.0 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing Activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of common stock and paid-in capital |
|
|
282 |
|
|
|
3,410 |
|
|
|
(3,128 |
) |
|
|
(91.7 |
)% |
Proceeds from borrowings |
|
|
540 |
|
|
|
- |
|
|
|
540 |
|
|
|
N/A |
|
Net cash provided by Financing Activities |
|
$ |
822 |
|
|
$ |
3,410 |
|
|
$ |
(2,588 |
) |
|
|
(75.9 |
)% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net decrease in cash, cash equivalents, restricted cash and
restricted cash equivalents |
|
$ |
(3,716 |
) |
|
$ |
(20,915 |
) |
|
$ |
17,199 |
|
|
|
(82.2 |
)% |
Effect of exchange rate changes on cash, cash equivalents,
restricted cash and restricted cash equivalents |
|
|
(14 |
) |
|
|
94 |
|
|
|
(108 |
) |
|
|
(114.9 |
)% |
Cash, cash equivalents, restricted cash and restricted cash
equivalents at the beginning of year |
|
|
4,412 |
|
|
|
33,619 |
|
|
|
(29,207 |
) |
|
|
(86.9 |
)% |
Cash, cash equivalents, restricted cash and restricted cash
equivalents at the end of period |
|
$ |
682 |
|
|
$ |
12,798 |
|
|
$ |
(12,116 |
) |
|
|
(94.7 |
)% |
Supplemental Non-GAAP Measures and Reconciliations
In addition to providing measures prepared in accordance with
GAAP, we present certain supplemental non-GAAP measures. These
measures are EBITDA, Adjusted EBITDA and Adjusted Net Income /
(Loss), which we use to evaluate our operating performance, for
business planning purposes and to measure our performance relative
to that of our peers. These non-GAAP measures do not have any
standardized meaning prescribed by GAAP and therefore may differ
from similar measures presented by other companies and may not be
comparable to other similarly titled measures. We believe these
measures are useful in evaluating the operating performance of
Advent’s ongoing business. These measures should be considered in
addition to, and not as a substitute for net income, operating
expense and income, cash flows and other measures of financial
performance and liquidity reported in accordance with GAAP. The
calculation of these non-GAAP measures has been made on a
consistent basis for all periods presented.
EBITDA and
Adjusted EBITDA
These supplemental non-GAAP measures are provided to assist
readers in determining our operating performance. We believe this
measure is useful in assessing performance and highlighting trends
on an overall basis. We also believe EBITDA and Adjusted EBITDA are
frequently used by securities analysts and investors when comparing
our results with those of other companies. EBITDA differs from the
most comparable GAAP measure, net income / (loss), primarily
because it does not include interest, income taxes, depreciation of
property, plant and equipment, and amortization of intangible
assets. Adjusted EBITDA adjusts EBITDA for items such as one-time
transaction costs, asset impairment charges, and fair value changes
in the warrant liability.
The following tables show a reconciliation of net loss to EBITDA
and Adjusted EBITDA for the three and six months ended June 30,
2024 and 2023.
EBITDA and Adjusted EBITDA |
|
Three months
endedJune 30,(Unaudited) |
|
|
|
|
|
Six months
endedJune 30,(Unaudited) |
|
|
|
|
(in Millions of US dollars) |
|
2024 |
|
|
2023 |
|
|
$ change |
|
|
2024 |
|
|
2023 |
|
|
$ change |
|
Net loss |
|
$ |
(11.27 |
) |
|
$ |
(21.83 |
) |
|
|
10.56 |
|
|
$ |
(20.63 |
) |
|
$ |
(33.82 |
) |
|
|
13.19 |
|
Depreciation of property and equipment |
|
$ |
0.40 |
|
|
$ |
0.81 |
|
|
|
(0.41 |
) |
|
$ |
1.12 |
|
|
$ |
1.21 |
|
|
|
(0.09 |
) |
Amortization of intangibles |
|
$ |
- |
|
|
$ |
0.19 |
|
|
|
(0.19 |
) |
|
$ |
- |
|
|
$ |
0.41 |
|
|
|
(0.41 |
) |
Finance income / (expenses), net |
|
$ |
0.06 |
|
|
$ |
(0.01 |
) |
|
|
0.07 |
|
|
$ |
0.29 |
|
|
$ |
(0.12 |
) |
|
|
0.41 |
|
Loss contingency |
|
$ |
(0.04 |
) |
|
$ |
- |
|
|
|
(0.04 |
) |
|
$ |
4.87 |
|
|
$ |
- |
|
|
|
4.87 |
|
Other income / (expenses), net |
|
$ |
2.46 |
|
|
$ |
0.81 |
|
|
|
1.65 |
|
|
$ |
2.48 |
|
|
$ |
0.76 |
|
|
|
1.72 |
|
Foreign exchange differences, net |
|
$ |
0.16 |
|
|
$ |
(0.16 |
) |
|
|
0.32 |
|
|
$ |
0.17 |
|
|
$ |
(0.12 |
) |
|
|
0.29 |
|
Income taxes |
|
$ |
- |
|
|
$ |
- |
|
|
|
- |
|
|
$ |
(0.06 |
) |
|
$ |
0.80 |
|
|
|
(0.86 |
) |
EBITDA |
|
$ |
(8.23 |
) |
|
$ |
(20.19 |
) |
|
|
11.96 |
|
|
$ |
(11.76 |
) |
|
$ |
(30.88 |
) |
|
|
19.12 |
|
Net change in warrant liability |
|
$ |
- |
|
|
$ |
(0.10 |
) |
|
|
0.10 |
|
|
$ |
(0.06 |
) |
|
$ |
(0.49 |
) |
|
|
0.43 |
|
Impairment losses |
|
$ |
- |
|
|
$ |
9.76 |
|
|
|
(9.76 |
) |
|
$ |
- |
|
|
$ |
9.76 |
|
|
|
(9.76 |
) |
Adjusted EBITDA |
|
$ |
(8.23 |
) |
|
$ |
(10.53 |
) |
|
|
2.30 |
|
|
$ |
(11.82 |
) |
|
$ |
(21.61 |
) |
|
|
9.79 |
|
This supplemental non-GAAP measure is provided to assist readers
in determining our financial performance. We believe this measure
is useful in assessing performance and highlighting trends on an
overall basis. Adjusted Net Loss differs from the most comparable
GAAP measure, net loss, primarily because it does not include
one-time transaction costs, asset impairment charges and warrant
liability changes. The following table shows a reconciliation of
net loss to Adjusted Net Loss for the three and six months ended
June 30, 2024 and 2023.
Adjusted Net Loss |
|
Three months
endedJune 30,(Unaudited) |
|
|
|
|
|
Six months
endedJune 30,(Unaudited) |
|
|
|
|
(in Millions of US dollars) |
|
2024 |
|
|
2023 |
|
|
$ change |
|
|
2024 |
|
|
2023 |
|
|
$ change |
|
Net loss |
|
$ |
(11.27 |
) |
|
$ |
(21.83 |
) |
|
|
10.56 |
|
|
$ |
(20.63 |
) |
|
$ |
(33.82 |
) |
|
|
13.19 |
|
Net change in warrant liability |
|
$ |
- |
|
|
$ |
(0.10 |
) |
|
|
0.10 |
|
|
$ |
(0.06 |
) |
|
$ |
(0.49 |
) |
|
|
0.43 |
|
Impairment losses |
|
$ |
- |
|
|
$ |
9.76 |
|
|
|
(9.76 |
) |
|
$ |
- |
|
|
$ |
9.76 |
|
|
|
(9.76 |
) |
Adjusted Net Loss |
|
$ |
(11.27 |
) |
|
$ |
(12.17 |
) |
|
|
0.90 |
|
|
$ |
(20.69 |
) |
|
$ |
(24.55 |
) |
|
|
3.86 |
|
Advent Technologies Holdings, Inc.
Dr. Vasilis Gregoriou,press@advent.energy
Source: Advent Technologies Holdings, Inc.
Advent Technologies (NASDAQ:ADN)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Advent Technologies (NASDAQ:ADN)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024